Inventor · disambiguated record
Luca Carta
Also filed as: CARTA LUCA
13 granted patents·7 pending applications·24 citations·filing 2016–2025
89Inventor score
Files withSHY Therapeutics LLC20
Top patents by PatentIndex Score
20 records- 0193US12168668B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2022·Granted Dec 17, 2024·1 cites·16 claims
- 0292US10870657B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2019·Granted Dec 22, 2020·4 cites·7 claims
- 0390US11026930B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2020·Granted Jun 8, 2021·2 cites·16 claims
- 0488US10588894B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2018·Granted Mar 17, 2020·4 cites·6 claims
- 0588US10221191B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2016·Granted Mar 5, 2019·5 cites·5 claims
- 0687US2025122216A1Compounds for the Treatment of Cancer and Inflammatory DiseaseSHY Therapeutics LLC·Filed 2024·Application pending·0 cites
- 0786US10940139B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 9, 2021·3 cites·27 claims
- 0885US11000515B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted May 11, 2021·2 cites·58 claims
- 0984US10933054B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Mar 2, 2021·2 cites·30 claims
- 1081US2023149369A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 1178US12391705B2Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2019·Granted Aug 19, 2025·1 cites·27 claims
- 1278US11541041B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, Rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 3, 2023·0 cites·39 claims
- 1376US11213515B1Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Granted Jan 4, 2022·0 cites·33 claims
- 1473US11560390B2Compounds for the treatment of cancer and inflammatory diseaseSHY Therapeutics LLC·Filed 2020·Granted Jan 24, 2023·0 cites·5 claims
- 1571US12459951B2Compounds that interact with RAS superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2024·Granted Nov 4, 2025·0 cites·46 claims
- 1669US2025296938A1Compounds that Interact with the Ras Superfamily for the Treatment of Cancers, Inflammatory Diseases, Rasopathies, and Fibrotic DiseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 1764US2025289825A1Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2025·Application pending·0 cites
- 1857US2024309015A1Methods for the Treatment of Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 1957US2024124483A1Methods for the Treatment of Fibrotic DiseaseSHY Therapeutics LLC·Filed 2022·Application pending·0 cites
- 2055US2023227466A1Substituted thienopyrimidines that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic diseaseSHY Therapeutics LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Luca Carta files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →